🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Occurrence of Abdominal Aortic Aneurysms in Patients With Aneurysmal Subarachnoid Hemorrhage

Recruitingn/aAges 18 Years - anyAllLeiden University Medical Center
NCT07312565 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Rationale: Aneurysms of different types are known to be associated. In literature, concurrence of intracranial- and aortic aneurysms is described. Screening for aortic aneurysms (AA) in patients with intracranial aneurysms (IA) or aneurysmal subarachnoid haemorrhage (aSAH) could be cost-effective and of significant importance to decrease morbidity and mortality. The available literature on the association between the two types of aneurysms is sparse and in general of poor methodological quality. This protocol presents a study to more adequately evaluate the association between IA and AA. Objective: To investigate the occurrence of abdominal aortic aneurysms (AAA) in patients who experienced aSAH. Study design: This single cohort prospective study will include patients who experienced aSAH. The study participants will receive an abdominal ultrasound of the aorta to detect an AAA. Study

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: In order to be eligible to participate in this study, a participant must meet all of the following criteria: * Patient is a study subject of the trial: Study on Prognosis of Acutely RupTured Aneurysms (SPARTA)(12) * Inclusion at least one year after aSAH * Written informed consent By being a study subject of the SPARTA trial, the following criteria are applicable: * Confirmed diagnosis of SAH on CT-scan or lumbar puncture (in the presence of a negative CT-scan) * IA related SAH as confirmed with radiological imaging * Age 18 years or older at presentation * Written informed consent for the SPARTA-trial Exclusion Criteria: A potential participant who meets any of the following criteria will be excluded from participation in this study: * Patient is not a study subject of the SPARTA trial * Patient has Loeys-Dietz-, Marfan- or Ehlers-Danlos syndrome
💊

What it tests

  • Not listed
📍

Where

1 site
LUMC
Leiden, Netherlands
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy